Abderrahim Fandi

Abderrahim Fandi currently serves as Chief Medical Officer at Smart Immune since November 2023. Prior to this role, Fandi was Chief Medical Officer at Oxford BioTherapeutics from March 2018 to April 2023. Fandi also held the position of Executive Director and site head at Celgene from January 2011 to January 2018, focusing on global clinical research and development. Previous experience includes serving as Executive Director at Novartis from June 2007 to January 2011 and as General Director at BMS from January 2005 to January 2007.